ITRM
NASDAQ · Pharmaceuticals
Iterum Therapeutics Plc
$0.00
-0.03 (-99.68%)
Open$0.00
Previous Close$0.03
Day High$0.00
Day Low$0.00
52W High$0.83
52W Low—
Volume—
Avg Volume115.5K
Market Cap746.1K
P/E Ratio—
EPS$-0.75
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 2.84M | 2.52M | 2.36M |
| Net Income | 737.1K | 595.8K | 463.7K |
| Profit Margin | 25.9% | 23.7% | 19.6% |
| EBITDA | 1.27M | 1.08M | 1.08M |
| Free Cash Flow | 617.3K | 603.4K | 596.2K |
| Rev Growth | +5.6% | +6.9% | +16.3% |
| Debt/Equity | 0.35 | 0.29 | 0.29 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,164.89 | +1.04% | 40.7 | 1.09T |
| JNJ | Johnson & Johnson | $269.47 | -0.19% | 30.6 | 644.12B |
| MRK | Merck & Co. Inc. | $149.50 | +1.79% | 114.0 | 361.66B |
| PFE | Pfizer Inc. | $27.74 | +0.29% | 36.4 | 157.54B |
| BMY | Bristol-Myers Squibb Co | $62.62 | -0.70% | 13.9 | 128.81B |
| ZTS | Zoetis Inc | $71.33 | -0.10% | 11.5 | 30.15B |